Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies

v3.22.2.2
Commitments and Contingencies
9 Months Ended
Sep. 30, 2022
Commitments And Contingencies Disclosure [Abstract]  
Commitments and Contingencies

11. Commitments and Contingencies

The Company’s commitments and contingencies consist primarily of unfunded commitments to extend credit in the form of loans to the Company’s portfolio companies. As of September 30, 2022, a portion of these unfunded contractual commitments are dependent upon the portfolio company reaching certain milestones before the debt commitment becomes available. Furthermore, the Company’s credit agreements with its portfolio companies generally contain customary lending provisions which allow the Company relief from funding obligations for previously made unfunded commitments in instances where the underlying portfolio company experiences materially adverse events that affect its financial condition or business outlook. Since a portion of these commitments may expire without being drawn, unfunded contractual commitments do not necessarily represent future cash requirements. As such, the Company’s disclosure of unfunded contractual commitments includes only those which are available at the request of the portfolio company and unencumbered by future or unachieved milestones.

As of September 30, 2022, and December 31, 2021, the Company had approximately $659.0 million and $286.8 million, respectively, of unfunded commitments, including undrawn revolving facilities, which were available at the request of the portfolio company and unencumbered by future or unachieved milestones. These amounts also exclude unfunded commitments related to the portion of portfolio company investments assigned to or directly committed by the Adviser Funds as described in "Note -12 Related Party Transactions". The fair value of the Company’s unfunded commitments is considered to be immaterial as the yield determined at the time of underwriting is expected to be materially consistent with the yield upon funding, given that interest rates are generally pegged to market indices and given the existence of milestones, conditions and/or obligations imbedded in the borrowing agreements.

As of September 30, 2022, and December 31, 2021, the Company’s unfunded contractual commitments available at the request of the portfolio company, including undrawn revolving facilities, and unencumbered by milestones were as follows:

(in thousands)

 

Unfunded Commitments (1) as of

 

Portfolio Company

 

September 30, 2022

 

 

December 31, 2021

 

Debt Investments:

 

 

 

 

 

 

Phathom Pharmaceuticals, Inc.

 

$

66,500

 

 

$

43,250

 

Oak Street Health, Inc.

 

 

44,250

 

 

 

 

Axsome Therapeutics, Inc.

 

 

42,000

 

 

 

 

Thumbtack, Inc.

 

 

40,000

 

 

 

 

Vida Health

 

 

40,000

 

 

 

 

Skydio, Inc.

 

 

37,500

 

 

 

37,500

 

HilleVax, Inc.

 

 

36,000

 

 

 

 

Automation Anywhere, Inc.

 

 

29,400

 

 

 

 

Iveric Bio Gene Therapy LLC

 

 

24,750

 

 

 

 

Brain Corporation

 

 

20,020

 

 

 

20,000

 

Aryaka Networks, Inc.

 

 

20,000

 

 

 

 

Finch Therapeutics Group, Inc.

 

 

20,000

 

 

 

 

G1 Therapeutics, Inc.

 

 

19,375

 

 

 

19,375

 

Tarsus Pharmaceuticals, Inc.

 

 

18,563

 

 

 

 

Locus Robotics Corporation

 

 

18,281

 

 

 

 

Alladapt Immunotherapeutics Inc.

 

 

15,000

 

 

 

 

ATAI Life Sciences N.V.

 

 

14,000

 

 

 

 

Dronedeploy, Inc.

 

 

12,500

 

 

 

 

Carbon Health Technologies, Inc.

 

 

11,625

 

 

 

11,625

 

Nuvolo Technologies Corporation

 

 

10,200

 

 

 

 

AppDirect, Inc.

 

 

10,000

 

 

 

 

Blue Sprig Pediatrics, Inc.

 

 

10,000

 

 

 

30,000

 

Dashlane, Inc.

 

 

10,000

 

 

 

19,300

 

RVShare, LLC

 

 

8,500

 

 

 

13,500

 

Viridian Therapeutics, Inc.

 

 

8,000

 

 

 

 

Elation Health, Inc.

 

 

7,500

 

 

 

 

Gritstone Bio, Inc.

 

 

7,500

 

 

 

 

Ouster, Inc.

 

 

7,000

 

 

 

 

Akero Therapeutics, Inc.

 

 

5,000

 

 

 

 

Alamar Biosciences, Inc.

 

 

5,000

 

 

 

 

Fulfil Solutions, Inc.

 

 

5,000

 

 

 

 

Demandbase, Inc.

 

 

3,750

 

 

 

9,375

 

Signal Media Limited

 

 

3,750

 

 

 

 

Riviera Partners LLC

 

 

3,500

 

 

 

 

Yipit, LLC

 

 

2,250

 

 

 

2,250

 

Khoros (p.k.a Lithium Technologies)

 

 

1,812

 

 

 

1,812

 

Ceros, Inc.

 

 

1,707

 

 

 

3,845

 

ThreatConnect, Inc.

 

 

1,600

 

 

 

1,600

 

Dispatch Technologies, Inc.

 

 

1,250

 

 

 

 

LogicSource

 

 

1,209

 

 

 

 

Zimperium, Inc.

 

 

1,088

 

 

 

 

Ikon Science Limited

 

 

1,050

 

 

 

1,050

 

Omeda Holdings, LLC

 

 

938

 

 

 

 

Alchemer LLC

 

 

890

 

 

 

 

Agilence, Inc.

 

 

800

 

 

 

800

 

Mobile Solutions Services

 

 

742

 

 

 

424

 

3GTMS, LLC

 

 

725

 

 

 

1,583

 

Constructor.io Corporation

 

 

625

 

 

 

 

Cybermaxx Intermediate Holdings, Inc.

 

 

471

 

 

 

471

 

Enmark Systems, Inc.

 

 

457

 

 

 

457

 

Annex Cloud

 

 

386

 

 

 

 

Gryphon Networks Corp.

 

 

268

 

 

 

268

 

Cytracom Holdings LLC

 

 

225

 

 

 

225

 

Syndax Pharmaceutics Inc.

 

 

 

 

 

30,000

 

Equality Health, LLC

 

 

 

 

 

17,500

 

Bicycle Therapeutics PLC

 

 

 

 

 

10,000

 

Better Therapeutics, Inc.

 

 

 

 

 

4,000

 

Logicworks

 

 

 

 

 

2,000

 

ShadowDragon, LLC

 

 

 

 

 

333

 

ePayPolicy Holdings, LLC

 

 

 

 

 

250

 

Pineapple Energy LLC

 

 

 

 

 

120

 

Total Unfunded Debt Commitments:

 

 

652,957

 

 

 

282,913

 

 

 

 

 

 

 

 

Investment Funds & Vehicles:(2)

 

 

 

 

 

 

Forbion Growth Opportunities Fund I C.V.

 

 

3,187

 

 

 

3,839

 

Forbion Growth Opportunities Fund II C.V.

 

 

2,826

 

 

 

 

Total Unfunded Commitments in Investment Funds & Vehicles:

 

 

6,013

 

 

 

3,839

 

 

 

 

 

 

 

 

Total Unfunded Commitments

 

$

658,970

 

 

$

286,752

 

(1)
For debt investments, amounts represent unfunded commitments, including undrawn revolving facilities, which are available at the request of the portfolio company. Amount excludes unfunded commitments which are unavailable due to the borrower having not met certain milestones. These amounts also exclude $203.2 million and $34.9 million of unfunded commitments as of September 30, 2022, and December 31, 2021, respectively, to portfolio companies related to loans assigned to or directly committed by the Adviser Funds as described in "Note -12 Related Party Transactions".
(2)
For investment funds and vehicles, the amount represents uncalled capital commitments in private equity funds.

The following table provides additional information on the Company’s unencumbered unfunded commitments regarding milestones, expirations and type:

(in thousands)

 

September 30, 2022

 

 

December 31, 2021

 

Unfunded Debt Commitments:

 

 

 

 

 

 

Expiring during:

 

 

 

 

 

 

2022

 

$

198,281

 

 

$

199,681

 

2023

 

 

312,457

 

 

 

43,675

 

2024

 

 

121,586

 

 

 

25,800

 

2025

 

 

1,694

 

 

 

2,232

 

2026

 

 

9,053

 

 

 

11,525

 

2027

 

 

7,745

 

 

 

 

2028

 

 

2,141

 

 

 

 

Total Unfunded Debt Commitments

 

 

652,957

 

 

 

282,913

 

Unfunded Commitments in Investment Funds & Vehicles:

 

 

 

 

 

 

Expiring during:

 

 

 

 

 

 

2030

 

 

3,187

 

 

 

3,839

 

2032

 

 

2,826

 

 

 

 

Total Unfunded Commitments in Investment Funds & Vehicles

 

 

6,013

 

 

 

3,839

 

Total Unfunded Commitments

 

$

658,970

 

 

$

286,752

 

The following tables provide the Company’s contractual obligations as of September 30, 2022 and December 31, 2021:

As of September 30, 2022:

 

Payments due by period (in thousands)

 

Contractual Obligations (1)

 

Total

 

 

Less than 1 year

 

 

1 - 3 years

 

 

3 - 5 years

 

 

After 5 years

 

Debt (2)(3)

 

$

1,542,000

 

 

$

 

 

$

377,000

 

 

$

800,000

 

 

$

365,000

 

Lease and License Obligations (4)

 

 

6,821

 

 

 

3,060

 

 

 

1,908

 

 

 

1,853

 

 

 

 

Total

 

$

1,548,821

 

 

$

3,060

 

 

$

378,908

 

 

$

801,853

 

 

$

365,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As of December 31, 2021:

 

Payments due by period (in thousands)

 

Contractual Obligations (1)

 

Total

 

 

Less than 1 year

 

 

1 - 3 years

 

 

3 - 5 years

 

 

After 5 years

 

Debt (5)(3)

 

$

1,250,425

 

 

$

380,000

 

 

$

105,000

 

 

$

574,925

 

 

$

190,500

 

Lease and License Obligations (4)

 

 

8,283

 

 

 

3,120

 

 

 

2,958

 

 

 

1,427

 

 

 

778

 

Total

 

$

1,258,708

 

 

$

383,120

 

 

$

107,958

 

 

$

576,352

 

 

$

191,278

 

(1)
Excludes commitments to extend credit to the Company’s portfolio companies and uncalled capital commitments in investment funds.
(2)
Includes $175.0 million in principal outstanding under the SBA Debentures, $105.0 million of the July 2024 Notes, $50.0 million of the February 2025 Notes, $70.0 million of the June 2025 Notes, $50.0 million of the June 2025 3-Year Notes, $50.0 million of the March 2026 A Notes, $50.0 million of the March 2026 B Notes, $150.0 million of the 2031 Asset-Backed Notes, $40.0 million of the 2033 Notes, $325.0 million of the September 2026 Notes and $350.0 million of the January 2027 Notes as of September 30, 2022. There was also $25.0 million outstanding under the SMBC Facility and $102.0 million outstanding under the MUFG Bank Facility as of September 30, 2022.
(3)
Amounts represent future principal repayments and not the carrying value of each liability. See “Note 5 – Debt”.
(4)
Facility leases and licenses including short-term leases.
(5)
Includes $150.5 million in principal outstanding under the SBA Debentures, $150.0 million of the 2022 Notes, $105.0 million of the July 2024 Notes, $50.0 million of the February 2025 Notes, $70.0 million of the June 2025 Notes, $50.0 million of the March 2026 A Notes, $50.0 million of the March 2026 B Notes, $40.0 million of the 2033 Notes, $325.0 million of the September 2026 Notes, and $230.0 million of the 2022 Convertible Notes as of December 31, 2021. There was also $29.9 million outstanding under the SMBC Facility and no amounts outstanding under the Union Facility as of December 31, 2021.

Certain premises are leased or licensed under agreements which expire at various dates through December 2028. For the three and nine months ended September 30, 2022, total rent expense, including short-term leases, amounted to approximately $0.8 million and $2.4 million, respectively. For the three and nine months ended September 30, 2021, total rent expense, including short-term leases, amounted to approximately $0.8 million and $2.4 million, respectively. The Company recognizes an operating lease liability and a ROU asset for all leases, with the exception of short-term leases. The lease payments on short-term leases are recognized as rent expense on a straight-line basis. The discount rate applied to measure each ROU asset and lease liability is based on the Company’s incremental weighted average cost of debt. The Company considers the general economic environment and its credit rating and factors in various financing and asset specific adjustments to ensure the discount rate applied is appropriate to the intended use of the underlying lease. While some of the leases contained options to extend and terminate, it is not reasonably certain that either option will be utilized and therefore, only the payments in the initial term of the leases were included in the lease liability and ROU asset.

 

The following table sets forth information related to the measurement of the Company’s operating lease liabilities and supplemental cash flow information related to operating leases as of September 30, 2022, and 2021:

(in thousands)

 

Three Months Ended September 30, 2022

 

 

Three Months Ended September 30, 2021

 

 

Nine Months Ended September 30, 2022

 

 

Nine Months Ended September 30, 2021

 

Total operating lease cost

 

$

744

 

 

$

724

 

 

$

2,185

 

 

$

2,196

 

Cash paid for amounts included in the measurement of lease liabilities

 

$

642

 

 

$

578

 

 

$

2,411

 

 

$

1,733

 

 

 

 

As of September 30, 2022

 

 

As of September 30, 2021

 

Weighted-average remaining lease term (in years)

 

 

4.17

 

 

 

4.37

 

Weighted-average discount rate

 

 

4.53

%

 

 

4.87

%

The following table shows future minimum lease payments under the Company’s operating leases and a reconciliation to the operating lease liability as of September 30, 2022:

(in thousands)

 

As of September 30, 2022

 

2022

 

$

652

 

2023

 

 

2,500

 

2024

 

 

848

 

2025

 

 

887

 

Thereafter

 

 

1,804

 

Total lease payments

 

 

6,691

 

Less: imputed interest

 

 

(599

)

Total operating lease liability

 

$

6,092

 

The Company may, from time to time, be involved in litigation arising out of its operations in the normal course of business or otherwise. Furthermore, third parties may try to seek to impose liability on the Company in connection with the activities of its portfolio companies. While the outcome of any current legal proceedings cannot at this time be predicted with certainty, the Company does not expect any current matters will materially affect the Company’s financial condition or results of operations; however, there can be no assurance whether any pending legal proceedings will have a material adverse effect on the Company’s financial condition or results of operations in any future reporting period.